chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After getting the moderna shot 3/19/21 on my left lef, reported adverse event; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (After getting the moderna shot 3/19/21 on my left lef, reported adverse event) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (After getting the moderna shot 3/19/21 on my left lef, reported adverse event). At the time of the report, VACCINATION COMPLICATION (After getting the moderna shot 3/19/21 on my left lef, reported adverse event) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided by the reporter. Treatment information was not provided.
Arms became itchy the day after immunization. Small raised bumps appear on both arms the evening after. 3-4 on each arm but no sign of fever or headache.
Received flu shot on Tuesday (12/13/2022). Tuesday patient states that she had a large reddened area at the injection site in the shape of an eye. It was warm to touch and had a knot under it. On Thursday on (12/15/2022) began to break out in a rash under bilateral arms, bilateral thighs, and behind bilateral knees. Patient states that they did itch but she takes allergy medication and patient states that she typically has a reaction to immunizations when given.
Sleepiness; Under injected arm, near left breast is tender and sore; Under injected arm, near left breast is tender and sore; Injected arm is very sore; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Sleepiness), TENDERNESS (Under injected arm, near left breast is tender and sore), PAIN (Under injected arm, near left breast is tender and sore), VACCINATION SITE PAIN (Injected arm is very sore) and FATIGUE (Tiredness) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 013M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included IRON for an unknown indication.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced SOMNOLENCE (Sleepiness), TENDERNESS (Under injected arm, near left breast is tender and sore), PAIN (Under injected arm, near left breast is tender and sore), VACCINATION SITE PAIN (Injected arm is very sore) and FATIGUE (Tiredness). At the time of the report, SOMNOLENCE (Sleepiness), TENDERNESS (Under injected arm, near left breast is tender and sore), PAIN (Under injected arm, near left breast is tender and sore), VACCINATION SITE PAIN (Injected arm is very sore) and FATIGUE (Tiredness) outcome was unknown.            Other relevant medication history included High Blood Pressure Medications. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.
Fever  - 8 hours  Vertigo - lasted for 8 hours or more  Headache  30 Hours  Muscle ache  12 hours  Thirst  Nausea
I had chest pain and shortness of breath. I went to ER where they gave pain reliever.
Patient with a history of having a rash and itching after receiving the flu vaccine.  She stated she discussed with her physician and he instructed her to get the covid-19vaccine.  Received the vaccine.    Received the vaccine and was sitting in observation and started to "feel itchy" at 1036.  Denies difficulty breathing, did state that "her throat feels scratchy, and feeling a panicky"  1040 wheeled to ED, Checked into room for treatment.
Difficulty swallowing, fever, cough, runny nose and petechial rash.
I started allergies/rash on face, neck and shoulders about six months after my second vaccine. I took Zyrtec and Benadryl to relieve my symptoms. The therapy was to increase your immunity against whatever I'm allergic too. The rash improved and tapered off. Since the booster it comes up every once in a while. The rash eventually lead to diagnoses of rheumatoid arthritis in May 2022. In February 2022 about fours months after booster, I had trouble with my heart. Chest pains, fainting spells and vomiting. I spoke to four different doctors and they all believe the vaccine contributed to her medical issues.
The patient developed and allergic reaction. She had a bumpy Itchy  rash that was spreading.  She took benadryl and motrin and stated that she is feeling better.  She also stated  that the reaction has subsided
I administered vaccine and applied a band-aid to patient's arm, she stood up and immediately sat back down, stating she was light- headed and that she does not like needles. She became pale and passed-out. She was unresponsive for approx. 20 seconds during which time my co-worker called 911. Pt was attended to by rescue workers and eventually walked out on her own, driven home by her father. Patient stated she thinks this happened to her a while ago when she got a vaccine because she is nervous about needles.
Pt. states that after receiving the 3rd Booster of Phizer 11/17/2021, started experiencing symptoms of pain in the neck and collarbone, armpit swelling (left arm), and vomiting. Symptoms have subsided but the armpit swelling remaining and increasing in the size. No noted Primary visit/communications.
Started with burning and pain my sternum Over to my left arm, managed it with ice packs, acetaminophen. Got somewhat better for a few weeks, now it's left arm, shoulder and up left side of neck. Hard to move left arm and turn head to left.
Left anterior thigh, swollen, sl red in palm sized area left inguinal nodes. Benadryl every 4-6 hrs OTC if uncomfortable.
mom states pt had fever the following day p/vax given @ 9AM but does not have a thermometer-only felt warm;also lt arm became red & swollen;21MAY98 lt arm redness & indurated measures 5 11/2cm in length & 4cm in width;
Within 20 mins of injection, extreme tightness & pain level 5 at base of skull to top of shoulders. ER following morning cldnt move head at all, pain level 8.  Now 25th symptoms still there , meds help very little. Pain level 7 much trouble sleeping.
Full body ached could hardly move, had a pounding headache for several days, skin hurt to the touch. Right arm was red and sore for several days, had chills and cold sweats. Body was flush.
Moderate diarrhea x 3 weeks after 2nd dose of Rotateq (8 X 1 day)
Developed mildly symptomatic COVID after vaccination. 05 Jan 2021:  Dose #1 Pfizer vaccine 13 Jan 2021:  Asymptomatic military screening performed. 14 Jan 2021:  Test result positive with onset of mild symptoms reported.  Managed with outpatient care and home isolation.
From initial info received on 4/21/03 from a health professional regarding an adverse event, it was reported that a 34 year old female pt received her second dose of YF-VAX on 4/21/03. Within seven to eight minutes after vaccination, the pt felt light headed, lower abdominal cramping and had diarrhea. Reportedly, the pt received her first dose of YF-VAX 10 years ago. The pt was taking Paxil and Desogen at the time of vaccination. Reportedly, the pt recovered from these evnets.
Fever, headache, nausea, muscle pain, back pain, fatigue, 'brain fog'
extremely bitter taste in the back of mouth on tongue; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): 20220547604 (Janssen).  A 27-year-old male patient received BNT162b2 (BNT162B2), on 18May2022 as dose 4 (booster), single) (Lot number: GA1188) at the age of 27 years for covid-19 immunisation. The patient's relevant medical history included: "Depression" (unspecified if ongoing). Concomitant medication(s) included: DULOXETINE, start date: Jul2020; AMLODIPINE BESILATE, start date: Mar2022; ALKA SELTZER PLUS FLU, start date: 18May2022. Vaccination history included: moderna (DOSE 1, Manufacturer : Moderna Covid Vaccine, Lot Number:038A21A, administered on right arm on 11Mar2021 for prophylactic vaccination, dose number in series 1, Past drug history: Spikevax (Elasomeran)), administration date: 11Mar2021, when the patient was 26-year-old, for Covid-19 immunization; moderna (DOSE 2, Manufacturer : Moderna Covid Vaccine, Lot Number:046821A, second dose on 20Apr2021 for prophylactic vaccination, dose number in series 1, Past drug history: Spikevax (Elasomeran).), administration date: 20Apr2021, when the patient was 26-year-old, for COVID-19 immunization; janssen coviD-19 vaccine (Covid-19 vaccine ad26.Cov2.s (Dose number in series 2) (suspension for injection, route of admin not reported, batch number: 20J12-03, and expiry: (Unknown) dose was not reported, 1 total administered on 21Dec2021,Causality as per reporter (Drug/Vaccine): Possible, Causality as per Mfr (Drug/Vaccine): Possible), administration date: 21Dec2021, when the patient was 27-year-old, for COVID-19 immunization, reaction(s): "Extreamly bitter taste in the back of tongue".  The following information was reported: DYSGEUSIA (non-serious) with onset 18May2022, outcome "not recovered", described as "extremely bitter taste in the back of mouth on tongue".  Additional information: It was unknown whether patient had any adverse events following vaccination with first two doses of Moderna (Spikevax) Covid-19 vaccine (Dose number in series 1). It was unknown whether patient had any adverse event following vaccination with first dose of covid-19 vaccine and ad26.Cov2.s (Dose number in series 2). On 18May2022, the patient experienced extremely bitter taste in the back of mouth on tongue, similar to bitter grapefruit. It woke patient up several times throughout the night (Dose number in series 3). This report was non-serious.   No follow-up attempts are possible. No further information is expected.
Nausea; Felt hot; Face turned flush; Itched all over but no rash; Tight chest; This is a spontaneous report from a non-contactable consumer, the patient. A 48-year-old, non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Apr2021 at 14:30 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history included allergies, asthma, penicillin allergy and Band-Aid allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took morphine and Demerol and experienced allergy to it. On 25Apr2021 at 14:30, the patient immediately felt hot, face turned flush, itched all over but no rash and tight chest. All symptoms only lasted 30 mins, except tight chest. The event tight chest lasted for two days. Other adverse reactions were consistent with known side effects and lasted for four days. After recuperating and feeling well for 6 days, on day 10 after dose 1 (on 05May2021), the patient suddenly experienced nausea for a duration of two days. Nausea was not a symptom the patient had previously. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of events felt hot, face turned flush and itched all over but no rash was recovered on 25Apr2021 at 15:00, tight chest was recovered on 27Apr2021 and nausea was recovered on 07May2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information expected.
This case was reported by a nurse via sales rep and described the occurrence of itchy rash in a 56-year-old female patient who received SHINGRIX (batch number LT533, expiry date 11th October 2020. On 23rd May 2018, the patient received SHINGRIX. On 25th May 2018, 2 days after receiving SHINGRIX, the patient experienced itchy rash, erythematous rash, papule, vesicles and skin lesion. The patient was treated with BENADRYL and Hydrocortisone Cream. On an unknown date, the outcome of the itchy rash, erythematous rash, pustule, vesicles and skin lesion were unknown. It was unknown if the reporter considered the itchy rash, erythematous rash, pustule, vesicles and skin lesion to be related to SHINGRIX. Additional details were provided as follows: On Friday afternoon in the same week of vaccination, the patient started to have bumps and developed into pustules all over arms and legs. The bumps were red, very itchy and fluid filled. The patient called physician on call. The patient took BENADRYL and put on some hydrocortisone cream. The patient still had lesions at the time of reporting but they seem to be getting better. The physician advised her not to get the second dose. They would be contacting medical science liaison for more information. The reported agreed to be followed up.
9/4 Redness, swelling, hot feeling at site. No evidence of fever. Arm was swollen according to pt. 9/6 Pt states swelling down but today swelling worse. Pt started on cephalexin 500 mg BID for cellulitis of the arm.  Right arm (Zostavax site).
BNT162B2 first dose 18Dec2020, second dose 06Jan2021; Severe sharp headache behind left eye; Severe nausea (but could be from headache).; Possible migraine; Mild photophobia; Mild photophobia; This is a spontaneous report from a contactable Physician who reported for herself. A 51-year-old female patient received her second single dose of BNT162B2 (Pfizer/ BioNTech Covid-19 vaccine, lot number EL3249) at left arm at 17:30 06Jan2021 for Covid-19 immunization in a hospital. She had her first injection at 07:15 PM 18Dec2020 and experienced mild photophobia within 5-10 min. The patient had a medical histroy of allergic rhinitis and was allergic to cashews. Concomitant medications included fexofenadine, colecalciferol (VITAMIN D), cyanocobalamin (VITAMIN B12). The patient did not receive any other vaccines within 4 weeks prior to her first COVID vaccine. Within 5-10 minutes of 2nd injection, the patient had mild photophobia (also after 1st injection but patient did not recognize the symptom at that time). About 20 hours after 2nd injection, the patient developed severe sharp headache behind left eye, severe nausea (but could be from headache/ possible migraine). The patient stated that she had no prior history of migraines or frequent headaches. Three days after 2nd dose, the patient's lingering intermittent mild left-sided headache persisted. The patient self-administered OTC oral analgesics. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Outcome of the events headache, nausea, migraine, photophobia at the time of last observation was resolving. The patient considered that the events were non-serious.
Pain during injection which was too high on arm. Arm hurt from then on.  Unable to lift arm over head or behind back. Have had physical therapy. Need to have shoulder manipulation under anesthesia followed by more physical therapy and possible additional surgery.
pt recv vax;that day,devel pain in shoulder,followed by swelling&2 wk later  "hard knot";tx w/ meds;
12 hrs prior to rxn, pt received DTP HBOC & OPV. Pt rxn: Rash
Sore left arm; Fatigued; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore left arm) and FATIGUE (Fatigued) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included Cataract in April 2021, Cataract operation (The patient had Cataract surgery on left eye on 06-MAY-2021) on 06-May-2021 and Cataract operation (The patient had Cataract surgery on right eyeon 21-MAY-2021) on 21-May-2021.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore left arm) and FATIGUE (Fatigued). At the time of the report, VACCINATION SITE PAIN (Sore left arm) and FATIGUE (Fatigued) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information was provided.   This case was linked to MOD-2021-185661, MOD-2021-182328, MOD-2021-182328 (Patient Link).
SERIOUSNESS CRITERIA: IMPORTANT MEDICAL EVENT. Initial solicited report received on 12DEC2017 from an investigator in a trial. This is a 28 year old female who received immunization with ACAM2000 05SEP2017. The patient had no prior cardiac or other relevant medical history. Other vaccines received within 30 days included immunization with BIOTHRAX, Japanese encephalitis and Typhoid ViCPs on 10AUG2017. On 20SEP2017 (15 days after smallpox vaccine) the patient had an abnormal electrocardiogram and troponin I (0.08), and a normal echocardiogram and was diagnosed with myocarditis, unspecified. On 22SEP2017, she was diagnosed with acute pericarditis. On 28SEP2017 she was diagnosed with acute myocarditis. At the time of the report the outcome was unknown. No further information was provided.
I became very warm, I was in a group and I felt nausea and I stood to go to the restroom and all of a sudden I just went down. When I came to, they gave me some water. The place that I was at had a nurse on duty and she took my blood pressure. My pressure was very high, I can't remember what it was. The place that I was at, their policy that had to call the EMT. Once I arrive at the ER, they did ran a lot of test and monitor my blood pressure. They kept me for a while and then they sent me home.
Fever, mother reported breathing difficulty at home prior to ER visit, diagnosed with influenza at ER visit.
Breakthrough case admission after 3 vaccines Pfizer 3/31/21 Lot# ER8730;  Pfizer 4/21/21 Lot# EW0162;  Pfizer 11/19/21 Lot# FJ8757;
Fever up to 102.2 with Tylenol. Chills. Nausea and vomiting. Weakness.
4 cm area of redness with slightly warm at site of Varicella injection. No drainage. 3-8-08 Dx: Allergic reaction to inj. Topicort Creme given. Date of Varicella 3-7-08
Near syncope after vaccine administration.  Did not loose consciousness.  BP dropped to 80/50 and recovered with recumbency.  EMS activated and patient transported to ED where she was seen and released.
Patient was vaccinated with the Moderna Covid-19 vaccine on 3-26-21 and 4-23-21. He was admitted to Hospital  on 06-08-2021. He tested positive for Covid-19 on 06-11-2021. He passed away on 06-12-2021. It is unknown whether or not Covid-19 contributed to the case's illness, hospitalization, possible adverse vaccine reaction or death.
It was reported that a 6 month old baby boy presented with encephalopathy in 2002 (date unknown) after the injection of poliomyelitis vaccine in November 2002. He was hospitalized and the outcome is unknown. File to be completed.
Started to feel ill night of vaccination.  Had chills, weakness and aches, dizziness and some loss of appetite. Symptoms were worst the next day (Friday). Each day the symptoms got lighter, by Sunday I felt almost back to normal. By Monday symptoms were gone. Used Advil to treat symptoms Thursday and Friday, by Saturday no longer needed Advil.   All in all, felt like a small replay of many of the symptoms I had back in mid November when I tested positive for COVID itself.
Pfizer 12+ 0.3 cc given instead of Pfizer 5-11 0.2 cc
Information has been received from a licensed vocational nurse (L.V.N.) referring to an unspecified number of patients of unknown age. On 01-APR-2015 the patients were vaccinated with an unspecified number of improperly stored dose of (Oka/Merck) VARIVAX, 0.5 ml/one time dose, subcutaneously for routine vaccination. No adverse effects reported. Additional information has been requested.
This case was reported by a physician and described the occurrence of a 43-year-old male subject not responding to therapy following vaccination with ENGERIX B, (GlaxoSmithKline).  Concurrent medical conditions included obesity.  In 2005 the subject completed a vaccination series of ENGERIX B and did not seroconvert.  A second series of ENGERIX B was administered with 1st, 2nd and 3rd dose in June 2007, July 2007 and the 3rd dose administered on 27 November 2007.  A titer completed in March 2008 was negative for antibodies.  The subject had again, not responded to therapy.  At the time of reporting the events were unresolved.  The physician considered the events were probably related to vaccination with ENGERIX B.
Tired, lethargic for 36 hours. Moderate to severe muscle pain in left bicep and shoulder for 48 hours.  Inflammation at injection site; skin painful to the touch.
Information has been received from a lawyer concerning a female who was vaccinated with Hep-B vaccine recombinant (yeast). Subsequently, the pt experienced hepatitis C which "caused chronic fatigue and fibromyalgia". According to the lawyer, she also had an anaphylactoid type of reaction "from the vaccine" followed by optic neuritis and "other evidence of" demyelinizing disease. Upon internal review, Hepatitis C, anaphylactoid type of reaction, optic neuritis and demyelinizing disease were considered to be "Other Important Medical Events". No further information is available.
Additional Pediarix given. patient had already received two doses of Pentacel and one dose of Pediatrix, so did not need the additional dose of Pediarix.  Moreover, it was given only two weeks after the prior Pediarix.
Yellow fever given 3-05-08.  Started Larium tabs 3-7-08 A.M.  Then noticed rash re: 7 pm 3-7-08 at injection site sq left arm.  Saturday 3-8-08 rash started spreading to elbow and under arm.  Fading now 3-10-08.  No fever.  Rash area warm to touch.  Better today 3-10-08.
Staff member reports shortness of breath, pain at injection site, swelling, redness and headache